US 11,053,281 B2
Peptoid affinity ligands
Andrew J. Murphy, Cary, NC (US); Tee Bordelon, Holly Springs, NC (US); and Michael Crapanzano, Baton Rouge, LA (US)
Assigned to MIKE-ANN, LLC, Baton Rouge, LA (US)
Appl. No. 16/83,361
Filed by MIKE-ANN, LLC, Baton Rouge, LA (US)
PCT Filed Mar. 9, 2017, PCT No. PCT/US2017/021655
§ 371(c)(1), (2) Date Sep. 7, 2018,
PCT Pub. No. WO2017/156319, PCT Pub. Date Sep. 14, 2017.
Claims priority of provisional application 62/305,831, filed on Mar. 9, 2016.
Claims priority of provisional application 62/305,835, filed on Mar. 9, 2016.
Prior Publication US 2019/0337980 A1, Nov. 7, 2019
This patent is subject to a terminal disclaimer.
Int. Cl. C07K 7/06 (2006.01); C07K 5/083 (2006.01); B01D 15/38 (2006.01); B01J 20/26 (2006.01); C07K 1/22 (2006.01); B01J 20/289 (2006.01); B01J 20/32 (2006.01); C07K 16/00 (2006.01); C07K 5/103 (2006.01); C07K 7/02 (2006.01); C07K 5/11 (2006.01)
CPC C07K 1/22 (2013.01) [B01D 15/3809 (2013.01); B01J 20/265 (2013.01); B01J 20/289 (2013.01); B01J 20/3204 (2013.01); B01J 20/3208 (2013.01); B01J 20/3212 (2013.01); B01J 20/3219 (2013.01); B01J 20/3274 (2013.01); C07K 5/0806 (2013.01); C07K 5/1008 (2013.01); C07K 5/1019 (2013.01); C07K 7/02 (2013.01); C07K 7/06 (2013.01); C07K 16/00 (2013.01); B01J 2220/52 (2013.01)] 5 Claims
OG exemplary drawing
 
1. A peptoid affinity ligand selected from the group consisting of:

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry
wherein the peptoid affinity ligand has a binding affinity to an immunoglobulin, immunoglobulin fragment or immunoglobulin fusion protein thereof.